Cohort Dashboard

GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.

Total Global Data

Unique Locations
Samples Expected
Samples Completed

Last Updated: April 23, 2024 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova

Showing 1 cohort study at Biomedical Research Foundation Academy of Athens.

Biological Markers in PD

National and Kapodistrian University of Athens | Athens, Greece
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 350 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 150 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 500 Expected

Submit a Cohort

If you would like to collaborate with GP2, reach out to submit a cohort or get more information on how to become a member.

Request AMP® PD Data Set

As GP2 completes cohort genotyping, all data is shared through the secured AMP® PD platform. Register to request access to this data.

Discover GP2 Members from Around the Globe

Explore the organizational members that make our research possible through their collaboration and contribution of samples and data.